• The high-resolution structure of the complex disulfidebonded TIL9E9 (D9) region of VWF is presented.
Introduction
The preservation of hemostatic integrity is secured by the activities of von Willebrand factor (VWF). Upon vascular damage, VWF acts as a molecular bridge facilitating the initial adhesion and aggregation of platelets to the site of vessel injury. Furthermore, VWF is the protective carrier of procoagulant factor VIII (FVIII) in plasma, thereby prolonging its half-life and efficiently localizing FVIII to the incipient platelet plug. 1, 2 The arrest of bleeding is critically dependent on VWF, as exemplified by von Willebrand disease (VWD), the most common inherited bleeding disorder in humans, which results from defective or deficient VWF protein. 3 The importance of VWF×FVIII complex formation is illustrated by patients with severe VWD, who have undetectable VWF levels. Not only do these patients have a concomitant deficiency of FVIII, but they also have a considerably shortened survival of intravenously administered FVIII. 1 This phenotype, which mimics hemophilia A, is also observed in patients with type 2N VWD, whose VWF harbors mutations that lead to decreased FVIII binding affinity. 4 This behavior reflects the dependence of FVIII survival on the formation of VWF×FVIII complexes and illustrates the biological significance of this interaction. Hence, the importance of elucidating the structure of the FVIII binding region on VWF is 2-fold. First, it would provide insights into the mechanism of FVIII binding to VWF and reveal the minimal VWF unit required to stabilize FVIII. Second, analysis of VWD patient mutations against a background of both structural and functional perturbations will provide the link between genetic pathology and clinical phenotype.
Electron microscopy studies have given a first glimpse of the domain arrangement and overall structure of the multidomain VWF protein 5 and in particular showed that the trypsin-inhibitor-like (TIL9) E9 domains form a protrusion from the D3 domain, thereby presenting the TIL9E9 domains to the physiological binding partner FVIII. However, the limited resolution of these structures has precluded the elucidation of the details needed to examine the molecular recognition and binding of FVIII to VWF. In addition, high-resolution structure determinations of the topologically complex disulfide-bonded VWF domains have not hitherto been feasible, except for the triplicated A domains, 6, 7 which are notable for their relative scarcity of cysteine residues. Thus, a detailed characterization of the interaction between VWF and FVIII has remained intractable, until now. The FVIII binding region on VWF has been identified within a tryptic fragment termed SPIII-T4 (residues 767-1031). 8 A recent domain assignment of VWF, based on conserved cysteine signatures, 9 reveals that SPIII-T4 is composed of 3 distinct and conserved domains, namely TIL9 (residues 766-827), E9 (residues 829-863), and VWD3 (residues 867-1031). Accumulated lines of evidence suggest that of these regions it is the TIL9 and E9 domains (Figure 1 ), previously known collectively as D9, that are essential for FVIII binding. 3 First, 72% of unique missense mutations that directly affect FVIII binding to VWF (type 2N VWD) are found in domains TIL9 and E9. 10 Importantly, the most severe type 2N phenotypes, characterized by the lowest circulating plasma FVIII levels, are due to mutations in TIL9 (Figure 1 and supplemental Figure 1 available on the Blood Web site). 4 Second, epitope-mapping studies of potent FVIII binding-blocking monoclonal antibodies (mAbs) mAb-418 (VWF epitope, residues 765-816) and mAb-32B12 (VWF epitope, residues 814-821) indicate that the putative FVIII binding site is localized to TIL9. 11, 12 Here, we present the solution structure and a characterization of the structural dynamics of the TIL9 and E9 domains of VWF. The TIL9E9 structure and dynamics provide an unprecedented view of the FVIII binding site on VWF and reveal a potential mechanism for the electrostatically guided VWF×FVIII interaction.
Materials and methods

Protein expression
The TIL9E9 coding sequence (residues 766-864) was amplified from fulllength VWF complementary DNA and cloned into a pET32b1 vector containing an N-terminal thioredoxin (TRX) and His 6 tag. The TRX-His 6 tag was separated from the TIL9E9 coding sequence by a 31-residue linker (SSGLVPRGSGMKETAAAKFERQHMDSPDLGT) and a tobacco etch virus (TEV) cleavage sequence (ENLYFQ↓G), leaving residues GAMG as cloning artifacts. Constructs of TIL9E9 were expressed in Escherichia coli SHuffle cells 13 and grown in ;4 L of either lysogeny broth or M9 minimal medium. Isotope-labeled samples were grown in M9 minimal medium supplemented with 2.5 g/L 13 N labeling) as the sole sources of carbon and nitrogen, respectively. For the 10% fractionally 13 C-labeled TIL9E9 used for stereospecific assignment of the Val and Leu side-chain methyl groups, the M9 medium was supplemented with 10% U- 13 C-glucose and 90% unlabeled glucose. Cells were grown to an optical density (OD) at 600 nm of ;0.6, and subsequent overexpression for 16 hours at 16°C was induced by the addition of 0.4 mM isopropyl-beta-D-thiogalactopyranoside.
Protein purification
After harvesting, the cells were resuspended in ;40 mL of wash buffer (20 mM sodium phosphate, 500 mM NaCl, 40 mM imidazole [pH 7.4]). To the cell suspension was added 1 tablet of Complete Protease Inhibitor (Roche), nonionic and nondenaturing detergent in the form of 0.25% octylphenyl-polyethylene glycol, lysozyme, and DNase (5-10 mg/mL). Cells were broken by French press and subsequently centrifuged, and the cleared lysate (;40 mL) was filtered (0.22 mm) and loaded onto a His-Trap Ninitrilotriacetic acid column (5 mL; GE Healthcare) pre-equilibrated with wash buffer. Bound protein was eluted using a linear gradient with increasing imidazole and pooled fractions dialyzed against 20 mM sodium phosphate, 100 mM NaCl (pH 7.4) for TEV proteolysis. TEV protease was added in the ratio of 1 OD 280 unit TEV per 5 to 10 OD 280 units of TRX-His 6 -TIL9E9; the reaction was incubated for 3 hours at room temperature and then at 4°C overnight to complete cleavage. Subsequently, the N-terminal TRX-His 6 tag was separated from the cleaved TIL9E9 fraction on the His-Trap nitrilotriacetic acid column. The TIL9E9 was loaded onto a 16/60 Superdex 75 column (GE Healthcare) pre-equilibrated with 20 mM sodium phosphate, 100 mM NaCl (pH 7.4) as a final purification step. Monomeric TIL9E9 was concentrated to 450 mL with final sample concentrations of 0.2 to 0.4 mM for further analyses.
Isotope-labeled 15 N and 13 C, 15 N samples were prepared in 20 mM sodium phosphate, 100 mM NaCl, 10% D 2 O at pH 7.4 for nuclear magnetic resonance (NMR) spectroscopy. Samples used for backbone residual dipolar coupling (RDC) measurements were prepared by adding Pf1 bacteriophage (ASLA Biotech, Latvia) 14 (;5 mg/mL) or pentaethylene glycol dodecyl ether (C 12 E 5 )/n-hexanol (Sigma-Aldrich) (3% wt/wt C 12 E 5 , r 5 0.94), 15 where r is the molar ratio of C 12 E 5 to n-hexanol, with corresponding deuterium quadrupolar splittings in Pf1 and C 12 E 5 /n-hexanol of ;1.5 Hz and 8 Hz, respectively.
Mass spectrometry
Recombinant TIL9E9 (10 mM) was buffer exchanged into 100 mM ammonium acetate (pH 7.0) for mass spectrometry (MS) experiments, which were carried out on a Synapt HDMS (Waters) mass spectrometer. 16 A 2.5-mL aliquot of the protein sample was delivered to the mass spectrometer by means of nanoelectrospray ionization using gold-coated capillaries (prepared in-house).
Ellman's reagents
Formation of all disulfide bonds was verified by an Ellman's assay with 5,59-dithio-bis-(2-nitrobenzoic acid) which reacts with a free sulfhydryl group to The amino-terminal 99 residues (residues 766-864) of the mature VWF protein comprise the TIL9 and E9 domains, which form the basis of this paper. Positionally conserved cysteine residues are highlighted in black and numbered sequentially. Yellow lines show disulfide connectivities, and an asterisk marks connectivities that have been previously chemically assigned. The circled Cys846-863 (2-6) disulfide connectivity of the E9 domain is assigned in this study. Type 2N VWD mutations are shown with arrows directly under the sequence together with the 1-letter code of the mutation; type 2N mutations involving a cysteine residue are in black, and noncysteine mutations are in green. Secondary structure elements (arrow, b sheet; line, loop; spiral, 3 10 helix) are shown under the sequence.
yield 2-nitro-5-thiobenzoic acid, which was detected spectrophotometrically at 412 nm. The Ellman's assay yielded ;0.1 mol free -SH per mol TIL9E9, thus confirming that essentially all cysteine residues are engaged in disulfidebond formation.
Binding of FVIII to plasma-derived VWF and recombinant TIL9E9 fragments
The potential FVIII binding partners (plasma-derived VWF, TIL9E9, reduced and alkylated TIL9E9) were coated directly onto a 96-well plate and incubated with an increasing concentration of FVIII. After equilibration and washing steps, bound FVIII was monitored with murine anti-FVIII and secondary antimouse horseradish peroxidase antibodies. Blanks were subtracted from the absorbance measurements, and 3 experiments were performed in duplicate. Details are given in supplemental Methods and materials.
NMR experiments
NMR experiments were recorded at 298 K on 500 MHz, 600 MHz, and 700 MHz spectrometers. Resonance assignments were obtained from a standard suite of triple-resonance 3-dimensional experiments (supplemental Methods and materials), and distance restraints were extracted from 15 N-and 13 C-edited nuclear Overhauser effect (NOE) spectroscopy spectra. RDCs were measured using aligned samples prepared in C 12 E 5 /n-hexanol 15 N steady-state heteronuclear NOEs) were measured at 600 MHz using standard methods 17 and analyzed according to the Model-Free formalism. 18 Relaxation dispersions were measured using a transverse relaxation optimized spectroscopy-selected Carr-Purcell-MeiboomGill (CPMG) experiment 19 at 500 MHz and 700 MHz and analyzed in terms of a 2-site exchange model.
Structure calculations
The solution structure of TIL9E9 was calculated from the experimental NMR restraints using the programs CYANA 20 and Xplor-NIH 21 with the standard scripts provided. The structures shown are those from the Xplor-NIH calculation. In total, 954 unique distance restraints were obtained, of which 353 are long range (between residues that are .5 residues apart in the primary sequence); details are given in supplemental Methods and materials.
Results
Recombinantly produced TIL9E9 is correctly folded and disulfide bonded
Based on predictions of the FVIII binding site on VWF (Figure 1 and supplemental Figure 1 ), the TIL9 and E9 domains (residues 766-864), which are located just after the Furin cleavage site (residues 763↓764) in the primary sequence of VWF, were selected for structural characterization. Previous homology modeling 9 predicted that all cysteine residues in TIL9E9 form disulfide bridges, of which 3 have been confirmed experimentally: Cys767-Cys808, Cys776-Cys804, and Cys810-Cys821 ( Figure 1 ). 22 Thus, isotopically labeled TIL9E9 for NMR structural and dynamic studies was obtained by overexpression in an E coli strain engineered to facilitate cytoplasmic disulfide-bond formation. 13 Correct pairing of the 16 cysteine residues, and hence correct folding of TIL9E9, was critically dependent on the expression of these domains downstream of an N-terminal thioredoxin tag, yielding an initial translation product that bears resemblance to the native VWF prodomains, which contain oxidoreductase-like sequences. 23 Recombinant TIL9E9 was analyzed by size-exclusion chromatography (supplemental Figure 2) , electrospray-ionization MS (supplemental Figure 3) , and Ellman's assay, which together confirmed that TIL9E9 was homogeneous, monomeric, and contained a negligible amount of free thiol groups. Compelling evidence that the TIL9E9 protein is well folded is provided by the very narrow charge-state distribution of the native MS profile (supplemental Figure 3) Figure 2 revealed a heterogeneous distribution of peak intensities, providing the first indication that the TIL9 and E9 domains possess differential flexibility.
Recombinant TIL9E9 binds to FVIII and mAb-418
The best reporter of TIL9E9 function is binding to FVIII; this is dependent upon the folded TIL9E9 adopting its biologically active 24 of the TIL9E9×FVIII interaction were undertaken to establish biological activity ( Figure 3) . Analysis of the binding assays showed that TIL9E9 binds to recombinant FVIII with an apparent affinity of 26 nM 6 2 nM, which is similar to the binding affinity of the SPIII-T4 fragment to FVIII (50-80 nM 25, 26 ). Reduced and alkylated TIL9E9 does not bind to FVIII, showing that the binding observed for TIL9E9 is due to specific rather than unspecific binding. Moreover, the binding affinity of the nonglycosylated TIL9E9 construct is at least as strong as the binding affinity of the slightly larger SPIII-T4 construct, demonstrating that glycosylation of TIL9E9 is not required for the specific TIL9E9×FVIII interaction. Using the same experimental setup, we also determined the binding affinity of plasma-derived VWF to FVIII, K d 5 0.9 nM, which is in the range of previously obtained results (eg, 0.52 nM, 25 1.5 nM 27 ), thus validating our result for recombinant TIL9E9. Binding of TIL9E9 to the conformation-dependent, FVIII binding-blocking VWF mAb-418 further confirmed the presence of a FVIII binding site on TIL9E9 (supplemental Figure 4) . Overall, the binding experiments performed suggest that the recombinantly produced TIL9E9 is a faithful representation of these domains in full-length VWF and retains their biological function. Importantly, the binding of TIL9E9 to FVIII shown in Figure 3 identifies TIL9 and E9 as the domains of VWF that contribute the majority of the VWF×FVIII binding free energy.
NMR assignments, verification of disulfide-bond topology, and structure of the TIL9E9 domains After establishing that the recombinantly produced TIL9E9 was both correctly folded and functional, the NMR resonances covering 78% of the TIL9E9 1 H, 13 C, and 15 N backbone nuclei were assigned using standard triple-resonance NMR experiments (Figure 2) . The unassigned nuclei are predominantly located between residues 781 and 805 of the TIL9 domain (supplemental Figure 5) , a consequence of resonance broadening due to micro-to-millisecond chemical exchange processes in this region of the protein (see below). The resonances of side-chain 1 H and 13 C nuclei were subsequently assigned using 3-dimensional carbon total correlated spectroscopy (CC-TOCSY)-based experiments to correlate the backbone resonances with those of the side chains, [28] [29] [30] giving a total assignment of 89% of the TIL9E9 nuclei. 15 N-and 13 C-edited NOE spectroscopy experiments were used to obtain 954 unique interresidue distance restraints (supplemental Table 1 ; supplemental Figure 6 ) for structure determination. In addition, 108 backbone dihedral-angle restraints (supplemental Table 2 ) were derived from the TIL9E9 chemical shifts, 31 and 361 vector-orientation restraints were collected by measurement of multiple RDCs in 2 alignment media (supplemental Table 3 ). 32 The disulfide-bonding pattern shown in Figure 1 
Cys i -Cys j represents a predicted disulfide bond between the i th and j th cysteine residues in the domain sequence (supplemental Figure 7) . This permitted the unambiguous assignment of 4 disulfide bridges, including Cys792-Cys827 in TIL9 and Cys829-Cys851, Cys849-Cys858, and Cys846-Cys863 in E9 that had been predicted 9 but not previously biochemically assigned (Figure 1 and supplemental Figure 7) . The overall disulfide-bonding topology was further confirmed by exclusion of the corresponding constraints from preliminary structure calculations. With the exception of the Cys788-Cys799 linkage and to some extent the Cys776-Cys804 linkage in the TIL9 domain, which were poorly defined due to limited NOE density, all predicted cysteine pairs came into close proximity. Therefore, all disulfide bonds were included as constraints in the structure calculation, resulting in the solution structure of VWF TIL9E9 shown in Figure 4 .
TIL9 has a long dominating loop, whereas E9 is all b sheet
The global fold of TIL9E9 shown in Figure 4 is crescent shaped, as has been suggested from electron microscopy imaging. 5 The structure clearly shows that TIL9 and E9 form independently folding domains, confirming the previous domain assignment separating D9 into the 2 distinct domains. 9 Salient features of domain TIL9 (residues 766-827) are the limited regions of secondary structure (;70% loop; 26% b strand) and lack of a significant hydrophobic core, such that 5 conserved disulfide bonds constitute the major stabilizing force constraining the fold (Figure 4 ). TIL9 is formed of 2 short b sheets, b1:b2 (residues 772-775:806-809) and b3:b4 (residues 814-817: 820-823), that form a scaffold bearing a long 30-residue loop, the b1-to-b2 loop. This loop encompasses an 8-residue insertion between the second and third conserved TIL9 cysteine residues as compared with structural homologs of TIL9 (supplemental Figure 1) . The second antiparallel b sheet, formed of strands b3 and b4, is connected by a reverse turn forming a small-hairpin structure. There is a single turn of a 3 10 helix (residues 824-826) at the C terminus of TIL9. TIL9 belongs to the Ascaris protease inhibitor family, defined by a 10-cysteine signature and a conserved protein fold, 33 with the closest structural homolog being a chymotrypsin inhibitor domain (Protein Data Bank accession number 1CCV) with a Z score of 3.6, as calculated by the DALI server. 34 In contrast, Figure 4 shows that the greater proportion of E9 is formed of a triple-stranded antiparallel b sheet formed of strands b3 (residues 839-844), b4 (residues 847-852), and b5 (residues 855-858). Additionally, the N terminus contains a short double-stranded b1:b2 sheet (residues 829-831:834-836). The relative positions of the 2 b sheets are restrained by the E9 Cys829-Cys851 disulfide bond. The 6-cysteine E9 domain was previously suggested to be a member of the fibronectin I-like superfamily of proteins 35 and thus similar to the von Willebrand factor type C (VWC) module. Supplemental Figure 8 shows an overlay of the structure of the E9 domain solved here by NMR spectroscopy and the first subdomain of a full VWC module. The 2 domains shown are structurally highly similar with a backbone root-mean-square deviation (RMSD) of 1.3Å, thus highlighting the structural similarities between the E9 domain and the VWC module.
The family of the 10 lowest-energy structures of TIL9E9 is well defined, with an average backbone pairwise RMSD of 1.12Å, and corresponding RMSDs for the TIL9 and E9 domains in isolation of 1.37Å and 0.34Å, respectively (supplemental Figure 9) . The backbone RMSD of the TIL9 domain excluding the long b1-to-b2 loop is 0.81Å, indicating that this loop dominates the structural heterogeneity of TIL9 and alluding to its intrinsic dynamic character (supplemental Figure 10) . The 10 lowest-energy structures have 73.1% of residues in the mostfavored regions in the Ramachandran plot, 22.3% in the additionally allowed regions, 3.4% in the generously allowed regions, and 1.2% in disallowed regions.
TIL9 is strikingly dynamic on at least 2 timescales
The conformational sampling of a protein is often essential to its biological activity, 36 and hence the dynamic characterization of TIL9E9 is of great importance for elucidating the mechanism by which FVIII is stabilized in plasma. The structural dynamics of TIL9E9 were quantified experimentally by 15 N nuclear spin relaxation experiments. 17 Analysis 15 N NOE ,0.6, whereas the backbone ribbon is colored red (blue) for residues whose R ex is greater (less) than 1.5 s
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. The backbone for residues where no R ex is available is colored gray. (E) Two representative dispersion profiles of residues with millisecond structural dynamics, Cys776 and Ser806. Points (vertical bars) represent measured R ex values (uncertainties), and the full-drawn line is a least-squares fit of a 2-site conformational exchange model to the data shown (red. 700 MHz; black, 500 MHz). Figure 5A ), which report specifically on backbone fluctuations on a pico-to-nanosecond (ps-ns) timescale, clearly show that, with the exception of the very C-terminal residues, the E9 domain is rigid with a uniform distribution of hetNOE values around 0.7. In contrast, several residues in the b1-to-b2 loop of the TIL9 domain show significantly lower NOE values, indicating a comparatively higher degree of flexibility. The amplitudes of the local ps-ns motions were quantified as squared order parameters, 18 S 2 , according to the model-free analysis of the 15 N spin relaxation rates (supplemental Table 4 ), and confirmed the relative flexibility of the TIL9 b1-to-b2 loop on this timescale. 37 The analysis of the 15 N relaxation rates includes a determination of the diffusion tensor, D. Of special interest here is the ratio of the parallel and the perpendicular components of the axial diffusion tensor, D || /D ' , because this ratio reports on the shape of the molecule. Firstly, the ratios obtained separately for the 2 domains are very similar (D ||,TIL9 /D ',TIL9 5 1.82 6 0.05 and D ||,E9 /D ',E9 5 1.9 6 0.1), which indicates that the TIL9 and E9 domains tumble as a single entity with only limited interdomain motion. Secondly, the relatively large values of D || /D ' confirm that the overall structure is a highly prolate spheroid, in agreement with the calculated structures ( Figure 4) .
Backbone dynamics on the broader pico-to-microsecond (ps-ms) timescale were investigated, because ligand binding and dissociation often takes place in this time regime. 36, 38 The amplitudes of motions over the ps-ms timescale were estimated from backbone chemical shifts 31 and subsequently included in structure calculations, 21, 39 together with the restraints listed above, to determine an ensemble of protein conformations that represent, simultaneously, the TIL9E9 structure and its associated dynamics. Accordingly, this structural ensemble represents a more faithful atomistic description of the conformational variability of TIL9E9 on a ps-ms timescale. The ensemble representation of TIL9E9 was systematically cross-validated by a combination of RDCs and side-chain 13 C methyl chemical shifts [40] [41] [42] [43] to give an optimal ensemble size of 10 replicas (supplemental Figure 11 ). The ensemble representation is shown in Figure 5B and shows that the b1-to-b2 loop is significantly more flexible than the remainder of TIL9E9.
Although the hetNOEs ( Figure 5A ) and chemical shifts report on ps-ns and ps-ms dynamics, respectively, structural dynamics on the millisecond timescale can be specifically probed using CPMG relaxation dispersion experiments. 19, 44 The time constants of many biochemical processes, such as ligand binding and dissociation, 36 are on the millisecond timescale, and CPMG experiments were therefore performed on the TIL9E9 domains to quantify such dynamics ( Figure 5C ). A first inspection of the CPMG data reveals localization of slower motions to the domain TIL9, particularly in the b1-to-b2 loop ( Figure 5C ), confirming the existence of a sparsely populated (excited) state with a lifetime in the millisecond range, whereas the E9 domain remains rigid on this timescale. A detailed analysis of the CPMG relaxation dispersions reveals that the ground state of TIL9E9 exchanges with an excited state; the lifetime of the excited state is approximately 0.5 ms and has a population of 3.5% (supplemental Methods and materials). Excited states often have significant functional roles in molecular recognition and ligand binding, and the existence of the TIL9E9 excited state is likely to be functionally relevant for the binding of VWF to FVIII.
A summary of the TIL9E9 dynamics is shown in Figure 5D , from which it is evident that the TIL9 b1-to-b2 loop is strikingly dynamic on at least 2 timescales, whereas the remainder of TIL9E9 provides a rigid scaffold supporting this conformationally dynamic entity.
Discussion
The solution structure and dynamic characterization of TIL9E9 allow an unprecedented interpretation of the likely functional consequence of type 2N VWD missense mutations. The greater proportion of the known type 2N missense mutations are distributed in the vicinity of the dynamic TIL9 b1-to-b2 loop ( Figure 6A ). Type 2N mutations that involve a cysteine residue (C788R/Y, Y795C, and C804F in TIL9; C858S/F in E9) are associated with aberrant multimerization, poor secretion, and reduced FVIII binding, 45 indicating that correct disulfide-bond formation is critical to the folding and function of VWF (Figure 3 ). Of the type 2N mutations, 3 account for the majority of cases reported (T791M, R816W, and R854Q), 10 of which R854Q occurs with polymorphic frequency, 4 and all of which are in immediate proximity to the b1-to-b2 loop. However, the most accurate reporters of the FVIII binding site are those mutations that are associated with a more severe type 2N phenotype; that is, E787K, T791M, and R816W. 10 Two of these mutations, T791M and R816W, together with T789P, M800V, R816Q, and H817Q, are clustered around a region of positive charge density on TIL9 ( Figure  6B-C) . Two regions on the FVIII light chain have been implicated in binding VWF, that is, the N-terminal acidic a3 domain and the C-terminal C2 domain. Although these 2 regions are thought to act synergistically in binding VWF, studies show that a3 in isolation binds ;8 times more strongly to VWF than the C2 domain, with affinities of ;72 nM and 564 nM, 46 respectively, and the acidic a3 domain is critical to high-affinity binding to VWF. 46 We therefore hypothesize that the positively charged and dynamic region on TIL9E9 is the major binding site to the negatively charged FVIII a3 domain. Thus, the deleterious effect of the R816W mutant is likely due to the introduction of a large and hydrophobic side chain and/or loss of positive charge (Table 1 47 ). Figure 6 shows that residues R782, G785, and E787 are on the opposite side of the structure yet in close proximity to the b1-to-b2 loop ( Figure 6 and supplemental Figure 12 ), which suggests that the severe type 2N mutation E787K, and mutations R782W and G785E, lead to deficiencies in FVIII binding through a perturbation of the b1-to-b2 loop, the upper portion of which borders the predicted binding region.
In summary, the majority of the noncysteine type 2N mutations ( Figure 6 ) are found in the vicinity of the flexible regions of TIL9, thereby localizing the FVIII binding site to this part of the VWF protein. Of the type 2N mutations in TIL9E9 involving charged residues, all but one result in loss of positive charge, supporting a predominantly electrostatic interaction between VWF and the FVIII light chain, which is in agreement with the fact that high ionic strength and low pH result in a much lower affinity of the VWF×FVIII complex. 27, 48 Hence, based on the foregoing analyses, we propose that E9 and the b sheets of TIL9 provide a rigid scaffold for the positively charged region on TIL9, which complements the charge distribution of the FVIII light chain to electrostatically guide VWF×FVIII complex formation.
The cysteine-rich N-and C-terminal flanking regions of VWF have been the subject of significant efforts aimed at characterizing the structure and plasticity of function of this unique protein. Superposition of the VWD type 2N missense mutations on the structure of TIL9E9, together with the characterization of its structural dynamics, reveals the malleable FVIII binding surface of VWF and represents an important step toward a detailed molecular understanding of these functionally important VWF domains for which atomicresolution structures have hitherto been unavailable. 
